New research unveiled at the American Association for Cancer Research meeting points to promising treatments for head and …
New research unveiled at the American Association for Cancer Research meeting points to promising treatments for head and …
Phase 2 study for Caliway’s CBL-514 highlights significant progress for Dercum’s disease, a rare and painful condition with …
New trial presents and preclinical readouts set to shape the oncology landscape
Phase III ASCENT-04/KEYNOTE-D19 trial reveals meaningful PFS improvement with a novel antibody-drug conjugate/immunotherapy combo
Enhertu combo shows promise in metastatic breast cancer while Arvinas reveals hopeful data on a novel lymphoma proteolysis …
FDA greenlights two major therapies offering new hope for patients with IgA nephropathy and giant cell arteritis
Zydus’ experimental therapy demonstrates significant improvements in liver function and patient outcomes, signaling new hope in a disease …
First new targeted therapy in more than a decade offers relief to patients with hives uncontrolled by antihistamines
New safety and efficacy evidence supports expanded use of mavacamten in oHCM patients
Funding boost fuels hopes for first disease-modifying treatment in a rare genetic disorder
